Monsanto Genocide - GMO Marijuana... I was right, again!

Monsanto and Bayer together Soros Open Society financing raised a new empire of Drug Industry. 

Monsanto pratically hold the monopoly of the marijuana nowadays and Soros is financing groups to legalize the drugs, specially marijuana, that makes the industry capable to sell it legally and in large scale. Also the logistic of drugs can be without the distributor, the drug trafficker, directly with the producer to the buyer.

Nowadays the legalization of drugs is not an utopia of the generations doomed by the revolting against the system, it's a case of investments and legal appliances together de governments. And with governments controling the distribution, the system will have an Oligopoly, by Monsanto and Bayer, and other large scale producers, and a Monopsony, when the only distributor has the control of the whole production of all the producers.

The legality of the distribution is making it easy do distrbute new stuffs, like the GMO Marijuada, the new K2 drug that made hundred of people with a fast overdose of the drug.

The Synthetic stuff makes a chemichal reaction in the oraganism and causes the effects of the natural product, the problem is that the marijuana acts directly in the brain and causes an effect adversial of the natural, with a faster overdose capacity and coma.

The K2 cannabis have a capacity of destroy the motor capacity and dump easily the user and the raising funds from the George Soros financial societies, the game is to spread more and more the synthetic stuff, and also the natural, with the legalization of other stuff, like cocaine, heroin, and other synthetic stuff.

Monsanto was working on GMO seeds to produce the effects of hybridism in the earth, and the earth will can only receive the seeds with the GMO DNA that Monsanto produces, this will make Monsanto have the monopoly of the whole world earth and plantations.

This is the start of the Genocide of world wide producers, with the rapidly development and sterilization of people who use some of these seeds, Monsanto together the global government is working on crowd controling and Soros helps to finace abortion and sterlization, drug spread, raising a dumb generation.

Soros now is having the whole information of Facebook, together Zuckerberg, Microsoft's CEO Bill Gates producing vaccines and leaving the vaccination campain to Africa and other poor countries on healthy system, and now Monsanto and Bayer producing the synthetic drugs and making people depend on their medicine to heal the problems they cause.

They have the cause and they have the cure for everything. The dialectic of the crowd control, make the problem and give the solution. Create the Drug and give the medicine to heal. Soros give what people wants, but don't what people needs.

In the end, I was right again months ago when I wrote about the GMO pot and the Monsanto and Bayer industry. At the end, the global banks, philantropists and industries are working to control the free thinking and destroy the tradition. Implementing the communist agenda of liberty of action or, also, the capitalist schedule of the free market and private drug lords.

That's the logic of these drug lords and industry of genocide.

'It's not just New Haven': mass K2 overdose symptom of national crisis

At least 95 people in New Haven overdosed on the drug in two days, as similar events become more common across the US

https://www.theguardian.com/society/2018/aug/17/k2-spice-synthetic-marijuana-new-haven-green-overdose

When a raised voice breaks out above the downtown din in New Haven Green park, the shouts are often drawing attention to yet another person who has had a bad reaction to the synthetic cannabinoid K2, also known as spice.

The drug users who frequent the 16-acre park in New Haven, Connecticut, which is just steps away from Yale University’s gothic campus, describe that reaction as a “fallout”, and so far it has happened to 95 people over the course of two days this week.

This mass, rapid-fire overdose event was a sped-up version of what is happening across the US as local and federal governments struggle to reduce the colliding impacts of opioid, methamphetamine, cocaine and other addictions.

Phil Costello, the clinical director for homeless care at Cornell Scott-Hill health center, works often in the Green from his temporary office under a tent. “That batch that came in yesterday, with all the people falling out, has just made this basically a mass casualty incident,” Costello said.

He and a team of other nurses and addiction counselors stood by cots, ready with bottled water and the overdose reversal agent narcan, which has proved largely ineffective against synthetic cannabinoids.

“I think it’s frustrating because for the team, because we don’t really have narcan that can fix it [the K2 overdoses],” Costello said. “It’s the addiction.”

In 2017, drug overdoses killed nearly 200 people per day, according to Centers for Disease Control and Prevention (CDC) data released this week, a new record driven by the deadly opioid epidemic.

Since K2 was first detected in the US in 2008, clusters of overdose outbreaks have become more and more common. About 56 people overdosed from K2 in Brooklyn in May; 100 people overdosed in Lancaster county, Pennsylvania, in July 2017 and 40 people overdosed in Dallas, Texas, in May 2014.

Sometimes K2 is laced with the powerful opioid fentanyl, but investigators including the federal Drug Enforcement Agency (DEA) said they have not yet found any in the New Haven sample.

Officials said there have not been any deaths from this batch of K2, but they fear the long-term consequences of a drug that causes hallucinations, vomiting and a rapid heart rate.

K2 is also known as synthetic marijuana because it interacts with cannabinoid receptors in the central nervous system to produce psychoactive effects. But K2 is much more potent and is an unpredictable mix of differing concentrations of different chemicals that are poured or sprayed on plant material.

Despite the mystery of each batch, K2 is appealing to drug users because its cost is low, its chemicals aren’t detected on standard drug tests and its changing mixtures make law enforcement efforts more complicated than with purer drugs such as marijuana.

“It’s just a daunting, daunting thought for the future,” said Costello. “This is a much bigger problem and a much bigger threat to national security than other things.”

Costello, a nurse, is known as “Dr Phil” to the hundreds of homeless who frequent the green and when not treating patients this week, he was constantly greeted by people he has helped in the past. “Everybody knows each other and they try to take care of each other the best they can,” Costello said.

The green has a manicured lawn and is surrounded by nice restaurants and cute shops, but it is also where people shoot drugs in the daytime and don’t hesitate to ask the stranger sharing a bench with them where to buy K2. It’s where hundreds of the city’s homeless spend their days, but the rest of the community doesn’t seem to linger.

Costello said on a normal day on the green, one or two people might need emergency medical care because of drug use. But not so with this batch, which police suspect was distributed by two men, including one accused of handing out it for nothing to lure in clients.

“With this particular version they have convulsions, psychotic episodes and become completely catatonic and barely responsive, which makes them very vulnerable to people who might want to take advantage of them,” Costello said.

At the peak of overdoses on Wednesday, 46 ambulances were responding to calls.

“People were dropping all over the green, it was just mass amounts of people,” said Daena Murphy, a clinical social worker at the community health center, Cornell Scott Hill Health Corporation, who worked alongside Costello this week.

“Fallout” rates slowed on Thursday, though in one 15-minute period, police and health workers darted around the park to respond to three distressed individuals.

A bystander or friend would call out, wave their arms and point at a victim lying on the ground or silent and still on a bench. In seconds, someone with a stethoscope, stretcher or water bottle would be running their way and ambulances would surround the scene.

Murphy warned that what had happened this week in this city of 129,934 people was happening across the US.

“After the TV cameras leave, we are still here,” Murphy said. “It’s not just New Haven.”

The dean of the Yale school of public health, Sten Vermund, said: “My fear is that the synthetic cannabinoids might be a new wave.”

“It’s occupying the fire department, the emergency room at Yale, you can imagine the pain and suffering of the patients’ families, on the patients themselves,” Vermund said. “It’s quite a big burden on a small city. It would be a big burden on a big city.”

Yale has been on the frontline of responding to the New Haven city green overdoses, with its emergency room caring for most of those affected and its pharmacologists analyzing the product and blood tests.

Vermund said: “This [K2] is a bit of a drug du jour but it’s in the context of a fairly substantial substance abuse crisis we have in the US.”

Why Genetically Modified Cannabis Probably Won't Be A Thing

Sadly, we probably won't see 100 percent THC nugs the size of watermelons anytime soon.

https://www.thekindland.com/products/why-genetically-modified-cannabis-probably-wont-be-a-thing-2843

The future of the legal marijuana industry in the United States is as indeterminable as today’s weed is intoxicatingly potent.  With legal marijuana laws springing up in states across the country, speculation of an eventual corporate presence in the cannabis industry is taking hold. And some think that when Big Agriculture enters the picture, with it will come strains of genetically modified marijuana.

“The cannabis industry should be aware that sooner rather than later, there will be big-ag at play in this industry,” Reggie Guadino of Berkeley, California-based Steep Hill Labs said to the Eureka Times-Standard.

Steep Hill Labs tests cannabis and marijuana products to provide different industry sectors with analytics and data on the legal dope currently on the Golden State market. And according to Guadino, Big Ag will likely begin to market said GMO weed soon. 

“The future is not necessarily a bad thing in respect to genetics of cannabis. It’s a matter of understanding what you can do with it,” Guadino told the Eureka Times-Standard. “I think a lot of people are afraid of it, because of genetics. Really it’s something that all agriculture does because it makes sense, because we have the tools and the technology and can do things in a more cost effective, intelligent manner,” he said.

Not everyone in the industry agrees with Guadino.

“I truly don’t think there is any GMO cannabis out there,” cannabis genetics expert and Marigene biochemist CJ Schwartz told High Times.

“So if you have a GMO plant you could introduce multiple copies of THC-synthase to produce more THC, but then there’s also ways that nature will do that by itself through gene duplication,” Schwartz explained.

To that end, many brands in the cannabis space already market strains or products they claim will elicit “targeted effects.” But any effects elicited from marijuana flower have more to do with the DNA, and cannabinoid content of the specific plant, and how those react with one’s endocannabinoid system––which is unique to everyone. 

“It’s still too early to definitively make those claims,” Kevin McKernan, a genetics researcher who was part of the team that first sequenced the cannabis genome and founder of Medicinal Genomics, said to KINDLAND.

“Now that we’re almost 800 samples deep, we’re seeing that the sativa vs. indica lines are becoming blurred. There is no longer a heavy distinction between these two genetically. We’re also a bit skeptical of subjective reviews given about strains. The effects they elicit are very individualized, patient-to-patient. You can’t really answer that question without also having the human genetics.”

Normally when one thinks of any genetically modified organism, the first name that comes to mind is Monsanto Company, the multinational agrochemical and agricultural biotechnology outfit responsible for genetically modifying America’s farm-grown produce. And when rumors of GMO weed first made rounds on the internet media cycle in 2016, even Monsanto took to their website to debunk the claims.

“Monsanto has not and is not working on GMO marijuana. This allegation is an Internet rumor,” reads the site.

Giving context to genetically enhanced, or modified marijuana, genetics researcher and Phylos Bioscience CEO Mowgli Holmes said to the Eureka Times-Standard:

“I don’t think there is anything that GMOs could do for cannabis that we need, that couldn’t be done by advanced plant breeding technique. GMOs can make cannabis that glows in the dark, but we don’t need that.”

Holmes is probably right. And even though we don't need it, admittedly, glow-in-the-dark weed would be pretty tight.

MONSANTO CREATES FIRST GENETICALLY MODIFIED STRAIN OF MARIJUANA

https://worldnewsdailyreport.com/monsanto-creates-first-genetically-modified-strain-of-marijuana/

St-Louis, MO | Monsanto, the multi-billion agribusiness giant, has announced today it has patented the first genetically modified strain of marijuana.

The news that has been welcomed by scientists and leaders of the agriculture business alike as a move forward towards the industrial use of marijuana and hemp products could bring a major shift towards marijuana policies in the U.S.A. and ultimately, to the world.

Under present US federal law, it is illegal to possess, use, buy, sell, or cultivate marijuana, since the Controlled Substances Act of 1970 classifies marijuana as a Schedule I drug, although it has been decriminalized to some extent in certain states, Monsanto’s interest in the field has been interpreted by experts as the precursor to “a major shift in marijuana policy in the US” as it is believed the company would not have invested so much time and energy if it had not had “previous knowledge” of the Federal government’s “openness” towards the future legalization of marijuana.

Lawyer and marijuana law specialist, Edmund Groensch, of the Drug Policy Alliance, admits Monsanto’s involvement in marijuana projects could definitely help the pro-legalization activists.

“Currently, Federal law criminalizes marijuana and hemp derivatives because public opinion is still against it and legal commercial production in the U.S. is currently handled by a patchwork of small farmers whom are not trusted by investors. A major player as Monsanto could bring confidence within government and towards investors in the market if it were to own a large part of the exploitable lands and commercial products”. 

“There is presently no way to control the production of marijuana and the quality of the strains. A GM strain produced by a company with the credentials and prestige of Monsanto would definitely lend a massive hand to pro-legalization activists within certain spheres of government and within the business world” he explains.

Although Monsanto’s testing on cannabis is only at an experimental stage, no plan has yet been released by the agriculture business firm as to what purposes the patented strain would be used for, although specialists believe answers should come this fall as rumors of a controversial new bill which could “loosen up laws around medical marijuana” is reportedly scheduled to pass before congress coming this fall.

Critics fear genetically modified cannabis will mix with other strains and could destroy the diversity of DNA, a reality dismissed by most studies claim experts.